The joint venture, called Sanara Ventures, said it had already invested in two companies: Kaleidoscope Medical, which has developed a system for X-ray radiation shielding during catheterisation procedures; and MGD, which is creating a portable device for measuring lung function in patients with Chronic Obstructive Pulmonary Disease.
Sanara Chief Executive Assaf Barnea said the venture had made another two investments that could not yet be disclosed, and that two or three more were expected by the end of the year.
Sanara Chief Executive Assaf Barnea said it had made another two investments that could not yet be disclosed, and that two or three more were expected by the end of the year.
Frans Van Houten, CEO of Dutch firm Philips, said: "We see Sanara Ventures as a strategic way for Philips to tap into new developments in the health technology industry."
Erez Vigodman, his counterpart at Israel's Teva, the world's biggest gener ..
"We see Sanara Ventures as a strategic way for Philips to tap into new developments in the health technology industry," Philips CEO Frans Van Houten said.
Erez Vigodman, Van Houten's counterpart at Israel's Teva, the world's largest generic drugmaker, said the healthcare industry is being transformed as consumers devote more time and money to remaining healthy, rather than merely waiting to treat an illness.
"That is driving the space. It means we can't confine our business model to finding a new chemical entity," he said. "We need branded and generic drugs, medical devices and diagnostic capabilities."
Philips is contributing to a new preventative care business model with its first HealthSuite Labs co-creation center in the Netherlands. Opened earlier this fall, the facility is designed to spur digital healthcare innovation and supports healthcare organizations in the transformation towards connected and more value-based, patient-centered care models. Healthcare directors and general practitioners can work together in multidisciplinary teams with patients as well as clinical, design, digital and business experts on the co-creation and implementation of integrated care solutions to enhance self-management and continuity of care for patients.
Philips plans to roll out the HealthSuite Lab co-creation centers in Asia and the United States, bigwigs said.
The company also is collaborating with the regional care network Zorgnetwerk Midden-Brabant, which represents the Elisabeth-TweeSteden Hospital (Netherlands) as well as general practitioners, home care nurses, dietitians and patients in the region. Through the HealthSuite Labs co-creation center, the organizations are developing a new regional connected health model for people living with type-2 diabetes –-- the first such model in the Netherlands.
Under this model, people will be given access to and control over their own actionable health data. They also will be encouraged to set realistic personal goals to support them in making decisions that are important to their health and care management, PHilips executives noted in a news release. In this way, the project aims to enhance self-management for patients with diabetes and improve their quality of life. Other important goals are to decrease visits to caregivers, increase treatment and medication loyalty.
“Most of today’s healthcare budget goes to the fast-growing population of people living with chronic illness,” said Jeroen Tas, CEO of Healthcare Informatics Solutions and Services at Philips. “The pressure on global healthcare systems is increasing, requiring them to find alternative ways of care delivery. At the same time, people want to be more involved in managing their own health. Together, these factors are shifting healthcare’s focus from traditional hospital-based, treat-when-sick (acute) models towards prevention and continuity of care in or near one’s home. Our HealthSuite Labs co-creation center will help care providers speed up the development and implementation of new integrated, connected and patient-centric healthcare delivery solutions that enable these new models.”
Drawing on the effective collection, analysis and sharing of health data, the solutions developed in the HealthSuite Lab co-creation center will be enabled by the HealthSuite Digital Platform, Philips’ secure cloud-based IT infrastructure.
“We want patients to be more empowered to manage their condition and their health,” said Veronique Holtmaat, director of Zorgnetwerk Midden-Brabant. “For this we need to improve the collection and exchange of data that various professionals and patients collect and make that data relevant and actionable. By working with Philips in the HealthSuite Labs co-creation center, we gain access to a wealth of know-how plus insight from other stakeholders across the care continuum and can set the next steps in creating truly collaborative and patient-centric care delivery.”